Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No need to be rude and this isn't a stinky pinky, maybe you are on the wrong board!
Unreal......we are talking Ebola Cure, what's up with this stock?
Someone was bid sitting at .282 for 50,000, couldn't get em and raised it to .285, still can't get em. Maybe they should think about hitting the ask.
Someone is trying really hard to keep this down while they load up........too funny!
Someone is bid sitting for over 200K! Wowwwwwwwwwww
Everytime those big walls show up on the ask, they then disappear and it shoots up......seems to be a pattern here, hoping this is day 1 of at least a 3 day run.
HEB.....Amex Stock.
They are trying to hold it back, someone did some serious accumulating this morning. Honestly, if I have Ebola and given the survival rate untreated, I am pretty sure I am going to be ok with trying a drug that has just given a 100% survival rate, whether it's only on mice so far or not!
Tiny biotech says it may have an answer for Ebola
12:08p ET February 2, 2015 (MarketWatch)
Tiny biotech says it may have an answer for Ebola
By Russ Britt, MarketWatch
Company says drug proved 100% effective in lab mice tests
LOS ANGELES (MarketWatch) -- A tiny biotechnology company said Monday that it just may have an effective treatment for the deadly Ebola virus.
But there's one catch: Hemispherx Biopharma Inc. (HEB) has only used its experimental drug on rodents thus far.
Hemispherx said in a press release issued Monday that it achieved a 100% success rate in treating Ebola-infected mice in tests of its drug known as Ampligen, conducted by the U.S. Army Medical Research Institute of Infectious Disease.
The company says Ampligen, which has yet to be evaluated by the U.S. Food and Drug Administration, was administered 50,000 times and was well-tolerated on a twice-weekly basis. The drug was 100% effective when used at doses that correspond with human doses of 400 milligrams.
With higher doses, the survival rate among mice was 90%. Those mice receiving placebos instead of the drug died in all cases by the seventh day after being infected, Hemispherx says.
The company adds that Ampligen could also prove to be effective even if a strain of Ebola changes in structure. There is some concern that other treatments for Ebola may become obsolete as certain strains of the virus go through a genomic shift and render other medications ineffective.
Still, investors seem tentative about Hemispherx's prospects. Shares were up 13% in recent action, but that amounted to only a 3-cent gain on the stock to 25 cents.
They are trying to hold it back, someone did some serious accumulating this morning. Honestly, if I have Ebola and given the survival rate untreated, I am pretty sure I am going to be ok with trying a drug that has just given a 100% survival rate, whether it's only on mice so far or not!
Tiny biotech says it may have an answer for Ebola
12:08p ET February 2, 2015 (MarketWatch)
Tiny biotech says it may have an answer for Ebola
By Russ Britt, MarketWatch
Company says drug proved 100% effective in lab mice tests
LOS ANGELES (MarketWatch) -- A tiny biotechnology company said Monday that it just may have an effective treatment for the deadly Ebola virus.
But there's one catch: Hemispherx Biopharma Inc. (HEB) has only used its experimental drug on rodents thus far.
Hemispherx said in a press release issued Monday that it achieved a 100% success rate in treating Ebola-infected mice in tests of its drug known as Ampligen, conducted by the U.S. Army Medical Research Institute of Infectious Disease.
The company says Ampligen, which has yet to be evaluated by the U.S. Food and Drug Administration, was administered 50,000 times and was well-tolerated on a twice-weekly basis. The drug was 100% effective when used at doses that correspond with human doses of 400 milligrams.
With higher doses, the survival rate among mice was 90%. Those mice receiving placebos instead of the drug died in all cases by the seventh day after being infected, Hemispherx says.
The company adds that Ampligen could also prove to be effective even if a strain of Ebola changes in structure. There is some concern that other treatments for Ebola may become obsolete as certain strains of the virus go through a genomic shift and render other medications ineffective.
Still, investors seem tentative about Hemispherx's prospects. Shares were up 13% in recent action, but that amounted to only a 3-cent gain on the stock to 25 cents.
Anyone know the float on this? I added about 5000 shares and it took 4 fills to get them. Makes me think there's not a lot of shares available.
Fake wall disappeared......betting someone was loading up knowing what's ahead. JMHO
AMEX - HEB - EBOLA Treatment NEWS......http://www.hemispherx.net/content/investor/default.asp?goto=814
Hemispherx: U.S. Army Scientists (USAMRIID) Find Ampligen® Produces 100% Survival Rate in Ebola Virus Rodent Study
……Placebo Group had a 100% Death Rate
Think some folks are waking up and seeing the news?
Possible Ebola treatment is huge!
I don't like the way this one trades, some obvious manipulation. Bid sitting and flipping, someone is using this for a piggy bank......looks like to me anyhow.
The news came out, it looks like around 8:30 so probably not a lot have seen it yet. At least I'm hoping this might move it a bit.
I've looked at this stock so many times and wonder why it's so low.........not sure what the problem is. With a possible Ebola treatment, this thing should be flying!
Why is it funny?
I take it from that you have tried to contact them also?
Very poor business relations when your IR department doesn't respond.
As for the news, it will be great IF they can prove what they are required to prove with the extension. I hope for our sake they can.
BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, announced today its receipt of a favorable decision from the Listing Qualifications Department (the "Staff") of The NASDAQ Stock Market LLC ("NASDAQ"), which granted the Company's request for continued listing on NASDAQ, pursuant to an extension within which to evidence compliance with NASDAQ Listing Rule 5550(b) (the "Rule"). In the Company's case, the Rule requires the Company to evidence either a minimum of $2.5 million in stockholders' equity or a market capitalization of at least $35 million. The Company is diligently working to evidence compliance with the Rule on or before May 19, 2015, as required by the Staff.
So far, I still have zero response from IR...not a good thing for the company to ignore shareholders but will see what Monday brings. If they have to be tight lipped about something, that's fine, but you should still respond with something.
Wow, glad I took some profits when I did earlier today. Didn't think I'd have a chance to buy back in this cheap but hopefully Monday my cash will be free and I will get my chance. This is far from over, in my opinion. Still a NASDAQ stock tied to Abbott Labs., just needed a breather after going up all week, plus it's a Friday so you know the sellers will be there.
I understand that and I know there are games played but it's all to make money. I can see level 2 and I see what people do. I guess it just irritates me but everyone plays the game their own way. By the way, no response yet from IR. Guess they are either really busy or they do not respond to shareholders.
Good Luck to you.
Hope whoever is doing the sitting is happy now, instead of hitting the ask, just slow the momo and watch paint dry all for a few cents.......thanks!
Some serious bid sitting man, almost painful to watch.
Exactly! They would rather flip for a few dollars rather than help get it to where it should be. Makes me wanna go..Aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa! lol
Wow, didn't think whoever was bid sitting for that 30K at 1.13 was going to get it.......congrats if you do, going much higher.
I like that valuation! Company has been quiet, curious what they are up to. I have an e-mail in to the company with a couple questions, will let you know if I receive a response.
Someone always has to put the big wall up but that's ok, it will slowly be chipped away at and sucked up, just like every other day.
Early morning Friday flippers, then we move up again!
I think someone was hoping it would drop a little lower to load up those bid sitting amounts.......don't think it's happening, people are accumulating and locking up shares.
Not to mention what's short and see a lot of bid sitters down to $1.00....need to hit the ask.
Every day there is a new high of the day and the next day we surpass that high so tomorrow we will be above 1.14, IMHO.
Don't forget, they have to keep it over $1.00 to stay on NASDAQ......this is a no brainer!
QUIT SELLINGGGGGGGGGG
OMG.....HERE WE GOOOOOOOOOO
You could be correct. Based on the pattern I've seen, there have been blocks like that every day and every time the buying pressure shows up, those blocks disappear.
Seems to be a pattern for someone though....notice it quite a bit. Maybe it's someones way of slowing things down while they are accumulating......either way, it's irritating to me.
I agree.....there's a big 40K block up for sale at .96, that's a nice chunk of change.......dang, I could get my new car with that. lol
That is my opinion also, I am not in a panic, was just curious. I see this going up one way or the other.....on it's own or through Abbott. Yeahhhhh
Just a thought but has anyone been in touch with the company and questioned why Abbott is getting credit for BGMD's FDA approval? I know I haven't contact them, thought maybe someone else did. Would love to hear the words......BUYOUT RIGHT ABOUT NOW! :)
Still amusing how shares are bought then they drop the price.......geeeee, I don't see the manipulation there! lol